Xinyu Wu

机构：Chongqing University of Science and Technology, First Affiliated Hospital of Bengbu Medical College, Shanghai Institute of Pharmaceutical Industry · ORCID：0009-0009-9852-7057

发表论文 56 篇 · 总被引 331 次 · h-index 11

代表论文

• Discovery of GPX4 inhibitors through FP-based high-throughput screening (2023 · European Journal of Medicinal Chemistry · 被引 17)
• Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer (2023 · Frontiers in Pharmacology · 被引 15)
• Neurokinin‐1 receptor antagonist aprepitant regulates autophagy and apoptosis via ROS / JNK in intrahepatic cholangiocarcinoma (2024 · Liver International · 被引 10)
• Airway epithelial‐derived exosomes induce acute asthma exacerbation after respiratory syncytial virus infection (2024 · MedComm · 被引 8)
• Integrating network pharmacology and experimental verification to investigate the pharmacological mechanisms of Buzhong Yiqi decoction in the treatment of non‐small cell lung cancer (2023 · Chemical Biology & Drug Design · 被引 8)
• Diagnostic accuracy of [99mTc]pertechnetate scintigraphy in pediatric patients with suspected Meckel’s diverticulum: a 12-year, monocentric, retrospective experience (2025 · Frontiers in Medicine · 被引 7)